GB2265547B - Agent for suppression and interception of maillard reaction - Google Patents

Agent for suppression and interception of maillard reaction

Info

Publication number
GB2265547B
GB2265547B GB9305309A GB9305309A GB2265547B GB 2265547 B GB2265547 B GB 2265547B GB 9305309 A GB9305309 A GB 9305309A GB 9305309 A GB9305309 A GB 9305309A GB 2265547 B GB2265547 B GB 2265547B
Authority
GB
United Kingdom
Prior art keywords
interception
suppression
agent
maillard reaction
maillard
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9305309A
Other languages
English (en)
Other versions
GB2265547A (en
GB9305309D0 (en
Inventor
Norihiro Kakimoto
Kunie Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asai Germanium Research Institute Co Ltd
Original Assignee
Asai Germanium Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asai Germanium Research Institute Co Ltd filed Critical Asai Germanium Research Institute Co Ltd
Publication of GB9305309D0 publication Critical patent/GB9305309D0/en
Publication of GB2265547A publication Critical patent/GB2265547A/en
Application granted granted Critical
Publication of GB2265547B publication Critical patent/GB2265547B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/30—Germanium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB9305309A 1992-03-16 1993-03-15 Agent for suppression and interception of maillard reaction Expired - Fee Related GB2265547B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4091685A JPH05255130A (ja) 1992-03-16 1992-03-16 メイラード反応抑制改善剤

Publications (3)

Publication Number Publication Date
GB9305309D0 GB9305309D0 (en) 1993-05-05
GB2265547A GB2265547A (en) 1993-10-06
GB2265547B true GB2265547B (en) 1996-07-31

Family

ID=14033361

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9305309A Expired - Fee Related GB2265547B (en) 1992-03-16 1993-03-15 Agent for suppression and interception of maillard reaction

Country Status (11)

Country Link
US (1) US5352815A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH05255130A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100245571B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU659589B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2091651C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH685876A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4308374C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2689763B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2265547B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1271438B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW278036B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1143432A (ja) * 1997-07-25 1999-02-16 Biremo Sci:Kk 脳の老化抑制及び治療剤
CN1150034C (zh) 1998-08-24 2004-05-19 黑川清 羰基压力改善剂和腹膜透析液

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365997A (en) * 1972-05-25 1974-09-04 Asai K Medicament comprising an organo germanium sesquioxide compound
GB2211410A (en) * 1987-10-29 1989-07-05 Asai Germanium Res Inst Germanium compounds for reducing nephrotoxicity of cyclosporin
GB2211411A (en) * 1987-10-29 1989-07-05 Asai Germanium Res Inst Germanium compounds for improving reduced functions of organs caused by inhibited blood circulation
GB2233898A (en) * 1989-07-20 1991-01-23 Asai Germanium Res Inst Ophthalmic compositions containing organo-germanium compounds
EP0444931A2 (en) * 1990-02-28 1991-09-04 Sanwa Kagaku Kenkyusho Co., Ltd. Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5632485A (en) * 1979-08-24 1981-04-01 Pola Chem Ind Inc Preparation of organogermanium compound
DE3212817A1 (de) * 1982-04-06 1983-10-13 Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya Pharmazeutisch wirksame organische germaniumverbindungen und verfahren zu deren herstellung
JPS601317B2 (ja) * 1982-08-23 1985-01-14 紀博 柿本 親水性及び親油性を併せ有する有機ゲルマニウム化合物
JPS6041472A (ja) * 1983-08-16 1985-03-05 Refuorumu Syst Kk 美容・健康飲料
JPS60226592A (ja) * 1984-04-25 1985-11-11 Asai Gerumaniumu Kenkyusho:Kk 抗酸化剤
JPS61145115A (ja) * 1984-12-18 1986-07-02 Asai Gerumaniumu Kenkyusho:Kk 塵肺症患者用風邪症候群予防剤
JPS63107920A (ja) * 1986-06-18 1988-05-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
US4973553A (en) * 1987-09-09 1990-11-27 Asai Germanium Research Institute Salt or organogermanium compound and medicine containing the same
JPH01149723A (ja) * 1987-12-07 1989-06-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
JP2652556B2 (ja) * 1988-08-29 1997-09-10 株式会社浅井ゲルマニウム研究所 有機ゲルマニウム化合物及びその製造方法
US5008416A (en) * 1989-06-20 1991-04-16 Sanwa Kagaku Kenkyusho Co., Ltd. Organogermanium compound, process for the preparation of same as well as use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365997A (en) * 1972-05-25 1974-09-04 Asai K Medicament comprising an organo germanium sesquioxide compound
GB2211410A (en) * 1987-10-29 1989-07-05 Asai Germanium Res Inst Germanium compounds for reducing nephrotoxicity of cyclosporin
GB2211411A (en) * 1987-10-29 1989-07-05 Asai Germanium Res Inst Germanium compounds for improving reduced functions of organs caused by inhibited blood circulation
GB2233898A (en) * 1989-07-20 1991-01-23 Asai Germanium Res Inst Ophthalmic compositions containing organo-germanium compounds
EP0444931A2 (en) * 1990-02-28 1991-09-04 Sanwa Kagaku Kenkyusho Co., Ltd. Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA 116(3): 15646c & Atarashii Ganka, 8(7), pages 1159-64 *
CA 117(11):104203u & Amino Acids, 1(2), pages 263-278 *

Also Published As

Publication number Publication date
GB2265547A (en) 1993-10-06
FR2689763A1 (fr) 1993-10-15
TW278036B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-06-11
DE4308374C2 (de) 2002-01-03
IT1271438B (it) 1997-05-28
GB9305309D0 (en) 1993-05-05
ITMI930491A1 (it) 1994-09-15
CA2091651A1 (en) 1993-09-17
DE4308374A1 (de) 1993-10-07
CH685876A5 (fr) 1995-10-31
JPH05255130A (ja) 1993-10-05
KR930019210A (ko) 1993-10-18
US5352815A (en) 1994-10-04
KR100245571B1 (ko) 2000-03-02
AU659589B2 (en) 1995-05-18
FR2689763B1 (fr) 1995-04-28
AU3511893A (en) 1993-09-23
ITMI930491A0 (it) 1993-03-15
CA2091651C (en) 2003-09-23

Similar Documents

Publication Publication Date Title
AU7964294A (en) Fire suppression system and method for its use
ZA931864B (en) Compositions containing combinations of surfactants and derivatives of succinic acylating agent or hydroxyaromatic compounds and methods of using the same
GB9313579D0 (en) Method of stabilizing aerosol formulations
ZA931645B (en) Antitumor compositions and methods of treatment
PL325972A1 (en) Compositions for and methods of fighting against harmful fungi
HU9202420D0 (en) An activating agent for biosynthesis of gen macrolids
AU4233593A (en) Moving harness and method of use
PL325330A1 (en) Agent for and method of fighting against harmful fungi
AU5847794A (en) Suppression of myeloid cells
PL323138A1 (en) Pharmaceutic agent containing thiagabine chlorhydride and method of obtaining same
ZA941787B (en) Prevention of unwanted fire
ZW16893A1 (en) Initiation of blasting
GB2265547B (en) Agent for suppression and interception of maillard reaction
GB9216678D0 (en) Coating of components
GB9424910D0 (en) Decontamination of Metals
PL301355A1 (en) Sybstituted hydroxy cimmamides, method of obtaining them and agents containing such compounds and their application
PL300183A1 (en) Method of and agent for fighting agains insects
AU3512193A (en) Flexibility enhancement agent and method of use
GB2278620B (en) Protective walls and method of construction
AU1444992A (en) Blasting compound containing absorbent gel and prevention of dusting
HU9303222D0 (en) Suppression of autoignition
GB2269946B (en) Earthing of enclosures
PL299806A1 (en) Fire extinguishing agent and method of obtaining same
AU4663496A (en) Use of metallic borophosphates and agent containing the same
GB9204997D0 (en) Fire protection of structural members

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120315